(Q35939961)

11 August 2017

1 reference

title

Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion (English)

1 reference

11 August 2017

Fathia Gibril

1

1 reference

11 August 2017

Robert T Jensen

series ordinal

2

1 reference

11 August 2017

publication date

1 December 2004

1 reference

Current gastroenterology reports

11 August 2017

published in

1 reference

11 August 2017

volume

6

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

454-463

1 reference

Biliary stricture: is dilatation an acceptable alternative to operation?

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0067-5

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0067-5

Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0067-5

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0067-5

Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0067-5

Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study

21 January 2018

1 reference

12 December 2020

Alpha-subunit and human chorionic gonadotropin-beta immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours

1 reference

12 December 2020

Gastrointestinal endocrine tumours. Gastrinoma

1 reference

12 December 2020

Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

Diarrhoea due to circulating agents

1 reference

12 December 2020

Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature

1 reference

12 December 2020

Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study

1 reference

12 December 2020

Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.

1 reference

12 December 2020

Levels of alpha-subunits of gonadotropins can be increased in Zollinger-Ellison syndrome, both in patients with malignant tumours and with apparently benign disease

1 reference

12 December 2020

The tumor biology of gastrin and cholecystokinin

1 reference

12 December 2020

Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1).

1 reference

12 December 2020

Zollinger-Ellison syndrome. Clinical presentation in 261 patients

1 reference

12 December 2020

Esophageal function and occurrence of Barrett's esophagus in Zollinger-Ellison syndrome

1 reference

12 December 2020

Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.

1 reference

12 December 2020

Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.

1 reference

12 December 2020

Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas

1 reference

12 December 2020

Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment.

1 reference

12 December 2020

Surgery to cure the Zollinger-Ellison syndrome

1 reference

12 December 2020

Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori, and proton pump inhibitor therapy

1 reference

12 December 2020

A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome

1 reference

12 December 2020

Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.

1 reference

12 December 2020

A comparison between three commercial kits for chromogranin A measurements

1 reference

12 December 2020

Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?

1 reference

12 December 2020

Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

1 reference

12 December 2020

Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas

1 reference

12 December 2020

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

1 reference

12 December 2020

Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy?

1 reference

12 December 2020

Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.

1 reference

12 December 2020

Multiple endocrine neoplasia type 1: clinical and genetic topics

1 reference

12 December 2020

Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.

1 reference

12 December 2020

Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy

1 reference

12 December 2020

The chromogranin-secretogranin family

1 reference

12 December 2020

Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

Prognostic value of initial fasting serum gastrin levels in patients with Zollinger-Ellison syndrome.

1 reference

12 December 2020

Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome

1 reference

12 December 2020

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

1 reference

12 December 2020

Tumour markers in neuroendocrine tumours.

1 reference

12 December 2020

Overview of chronic diarrhea caused by functional neuroendocrine neoplasms.

1 reference

12 December 2020

Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1

1 reference

12 December 2020

Peptic ulcer perforation as the presentation of Zollinger-Ellison syndrome

1 reference

12 December 2020

Reflux esophagitis in patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas

1 reference

12 December 2020

Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones

1 reference

12 December 2020

Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment

1 reference

12 December 2020

Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.

1 reference

12 December 2020

Multiple endocrine neoplasia type 1

1 reference

12 December 2020

Hypergastrinemia in animals and man: causes and consequences.

1 reference

12 December 2020

Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas

1 reference

12 December 2020

Progastrin in pancreas and the Zollinger-Ellison syndrome

1 reference

12 December 2020

Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment

1 reference

12 December 2020

Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.

1 reference

12 December 2020

Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances

1 reference

12 December 2020

Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis

1 reference

12 December 2020

Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high

1 reference

12 December 2020

Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

10.1007/S11894-004-0067-5

Identifiers

DOI

1 reference

11 August 2017

1 reference